Stereotaxis
STXS
67 hedge funds and large institutions have $69.9M invested in Stereotaxis in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 11 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less capital invested
Capital invested by funds: $73.2M → $69.9M (-$3.28M)
10% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 21
1.96% less ownership
Funds ownership: 47.6% → 45.64% (-2%)
9% less funds holding
Funds holding: 74 → 67 (-7)
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
70% less call options, than puts
Call options by funds: $19K | Put options by funds: $64K
Top Buyers
Top Sellers
STXS Hedge Fund Activity: Q1 2023 in Review
67 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Stereotaxis (STXS) for Q1 2023, worth a combined $69.9M — down 4.5% from $73.2M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of STXS and 5 opened new positions — a net loss of 6 holders — while 21 trimmed existing stakes and 19 added.
The largest buyer was Essex Investment Management, adding an estimated $377K. The largest seller was Millennium Management, cutting an estimated $1.31M.
- 67 institutional investors held Stereotaxis (STXS) as of Q1 2023, down from 74 in Q4 2022.
- Funds reported $69.9M of Stereotaxis stock for Q1 2023, down 4.5% quarter-over-quarter.
- 5 funds opened new Stereotaxis positions in Q1 2023 and 11 closed out, a net change of -6 holders.
- The largest Stereotaxis buyer in Q1 2023 was Essex Investment Management, an estimated $377K added.
- The largest Stereotaxis seller in Q1 2023 was Millennium Management, an estimated $1.31M sold.
Based on aggregated 13F filings for Q1 2023.